December 13, 2013
EFPIA Japan

Jez Moulding becomes new chairman of EFPIA JapanTOKYO—December 13, 2013— EFPIA Japan announced today that Jez Moulding(President and Representative Director, Sanofi K.K., Senior Vice President, Japan &Pacific Region) has been appointed the new chairman of EFPIA Japan. He will officiallystart from January 1st, 2014.
The current chair, Philippe Fauchet (GlaxoSmithKline K.K.), at the end of his two-year
term, will become a vice chairman. Masao Torii (Nippon Boehringer Ingelheim Co., Ltd.)
will continue to serve in his current position of vice chairman. Both vice chairmen andfive directors will support Mr. Moulding in his new role. The Director General position willtransfer from Keiko Nakamura (GlaxoSmithKline K.K.) to Hidetaka Shimada (SanofiK.K.).
Mr. Moulding gave his vision for EFPIA Japan by saying,“As Japanese society changes, the Japanese healthcare environment also continues toevolve. In this era of reform, EFPIA, which consists of research-driven pharmaceuticalcompanies based in the EU, will continue to propose solutions to the many issues
facing the pharmaceutical industry. EFPIA supports maintaining the premium pricing
system to encourage innovation, expediting Japanese patients’ access to new andinnovative global products, reducing drug lag, and pursuing a better balance between
prevention and treatment in public health. We would like to further contribute to theimprovement of Japan’s healthcare system, and will always take a ‘patient first’approach.”
Contact：
Keiko Nakamura, Chairman, PR committee〒151-8566 4-6-15,Shibuya-ku, Sendagaya, Tokyo
GlaxoSmithKline KKTEL: 03-5786-3709
Mail: keiko.2.nakamura@gsk.com

1/2

Biography of Jez MouldingDate of Birth

Current position President and Representative Director, Sanofi K.K., Senior Vice President,
Japan & Pacific Region

Experience with the Sanofi Group

November 9, 1968 (Age 45)

February 2011

President and Representative Director, sanofi-aventis K.K. (Present “SanofiK.K.”), Senior Vice President, Japan & Pacific Region (Japan, Korea,Australia and New Zealand)

October 2010

President and Representative Director, sanofi-aventis K.K. (Present “SanofiK.K.”)

September 2007

General Manager, sanofi-aventis Australia and New Zealand

October 2005

General Manager, sanofi-aventis Korea

November 2002

General Manager, Sanofi-Synthelabo South Africa

May 2001

Associate Director Europe, Transversal Projects, Sanofi-Synthelabo France

July 2000

Head of Cardiovascular Marketing and Commercial, Sanofi-SynthelaboEnglandEducation1991

Others

2012
2010

Edinburgh University, MA in Social Science

Member of the board
Japan Pharmaceutical Manufacturers Association (JPMA)
Vice Chairman
European Federation of Pharmaceutical Industries and Associations (EFPIA)Japan

EFPIA Japan Board Members as of January 1st, 2014
Chairman:Vice Chairman:
Vice Chairman:
Director:
Director:
Director:
Director:
Director:
Director General:

Jez Moulding
Masao Torii
Philippe FauchetYoshiyasu Ninomiya
Carsten Brunn
Gabriel Baertchi
Claus Eilersen
James Feliciano
Hidetaka Shimada(Sanofi K.K.)(New)(Nippon Boehringer Ingelheim Co., Ltd.)(GlaxoSmithKline K.K.)(New)(Novartis Pharma K.K.)(Bayer Yakuhin, Ltd.)(AstraZeneca K.K.)(Novo Nordisk Pharma Ltd.)(Merck Serono Co., Ltd.)(EFPIA Japan)(New)
2/2